The role of somatostatin and dopamine receptors as molecular targets for the treatment of patients with pituitary adenomas.
Colao
A
A
Hofland
L J
LJ
D000236:Adenoma / Q000188:drug therapy*; D018491:Dopamine Agonists / Q000494:pharmacology; D006801:Humans; D010911:Pituitary Neoplasms / Q000188:drug therapy*; D011954:Receptors, Dopamine / Q000187:drug effects / Q000502:physiology*; D017481:Receptors, Somatostatin / Q000187:drug effects / Q000502:physiology*; D013004:Somatostatin / Q000031:analogs & derivatives
D018491:Dopamine Agonists; D011954:Receptors, Dopamine; D017481:Receptors, Somatostatin; D013004:Somatostatin